Boston Scientific Plans Restructuring To Save Up To $150m Annually
This article was originally published in The Gray Sheet
Executive Summary
The firm has not offered many details yet, except to say that the restructuring is focused on “developing global commercialization, technology, and manufacturing capabilities in key growth markets, continuing implementation of the company's plant network optimization strategy, and expanding operational efficiencies in support of the company's operating income margin goals.”